The Characteristics and Mechanisms of Visual Disturbance Associated with Anticonvulsant Therapy
Neurol 40:791-796, Remler,B.F.,et al, 1990
Carbamazepine-Induced Ophthalmoplegia
Arch Neurol 39:64, Mullally,W.J., 1982
Phenytoin-induced Ophthalmoplegia
Neurol 26:1031, Spector,R.H.,et al, 1976
Neurologic Manifestations of SLE 1972
Nebraska State Journ Med, Oct 1972, pp 395., Aita,J., 1972
Abducens Nerve Palsy in Dilantin Intoxication
J Pediatr 55:73-77, Manlapaz,J.S., 1959
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Myasthenia Gravis Assoc. with Wasp Sting
JAMA 235:2120, Brumlik,J., 1976
Early Child Development and Exposure to Antiepileptic Drugs Prenatally and Through Breastfeeding
JAMA Neurol 70:1367-1374, Veiby, G.,et al, 2013
Child Development Following In Utero Exposure: Levetiracetam vs Sodium Valproate
Neurol 76:383-389, Shallcross,R.,et al, 2011
Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003
Sensorineural Hearing Loss: A Reversible Effect of Vigabatrin
Neurol 61:1020-1021, Papdeas,E.,et al, 2003
Acute Myopia and Angle-Closure Glaucoma Induced by Topiramate
Neurol 61:1306, Boentert,M.,et al, 2003
Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002
Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002
Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Valproic Acid Hepatic Fatalities. III. U. S. Experience Since 1986
Neurol 46:465-469, Bryant,A.E.&Dreifuss,F., 1996
Carbamazepine Hypersensitivity Syndrome:Report of 4 Cases & Review of Literature
Medicine 74:144-151, DeVriese,A.S.P.,et al, 1995
Prolonged Absence Status epilepticus Assoc with Carbamazepine, Increased ICP & Trans MRI Abnor
Neurol 42:2198-2201, Callahan,D.J.&Noetzel,M.J., 1992
Sensorineural Hearing Loss:A Reversible Effect of Valproic Acid
Neurol 40:1896-1898, Armon,C.,et al, 1990
Pattern of Malformations in the Children of Women Treated with Carbamazepine During Pregnancy
NEJM 320:1661-1666, Jones,K.L.,et al, 1989
Teratogenic Effects of Carbamazepine
Letter, NEJM 321:1480-14811989., , 1989
The Toxic Effects of Anticonvulsant Drugs in Long-Term Treatment of Epilepsy
JNNP 52:1116, Raman,R.,et al, 1989
Phenytoin Neuropathy:Structural Changes in the Sural Nerve
Ann Neurol 19:162-167, Ramirez,J.A.,et al, 1986
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Drug Therapy, Clonazepam
NEJM 299:812-816, Brown,T.R., 1978